Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension



Rating:

Share or cite this content

Citations should be made in the following way:
A. FAUCHE (BREST, France), E. Presles (SAINT ETIENNE, France), O. Sanchez (PARIS, France), X. Jaïs (PARIS, France), R. Le Mao (BREST, France), P. Robin (BREST, France), G. Pernod (GRENOBLE, France), L. Bertoletti (GRENOBLE, France), P. Jego (RENNES, France), F. Parent (PARIS, France), C. Lemarie (BREST, France), F. Leven (BREST, France), P. Le Roux (BREST, France), P. Salaun (BREST, France), M. Nonent (BREST, France), P. Girard (PARIS, France), K. Lacut (BREST, France), L. Savale (PARIS, France), S. Melac (BREST, France), M. Guégan (BREST, France), P. Mismetti (SAINT ETIENNE, France), S. Laporte (SAINT ETIENNE, France), C. Leroyer (BREST, France), D. Montani (PARIS, France), F. Couturaud (BREST, France), C. Tromeur (BREST, France). Frequency and risk factors for Chronic Thromboembolic Pulmonary Hypertension after a first unprovoked Pulmonary Embolism: results from PADIS-studies.. 172

Member's Comments

No comment yet.

Related content which might interest you: Treatment of Chronic Thromboembolic Pulmonary Hypertension: A new approach Source: International Congress 2018 – CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension Year: 2018 Chronic Thromboembolic Pulmonary Hypertension related to ICD Source: International Congress 2018 – CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension Year: 2018 Incidence of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) at six months of a Pulmonary Embolism (PE). OSIRIS Study Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism Year: 2017 Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Interventional Treatment in Chronic Thromboembolic Pulmonary Hypertension with Microvasculopathy Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020 Risk factors of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Prognosis factors of recurrent pulmonary thromboembolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 The incidence of chronic thromboembolic pulmonary hypertension in asympthomatic pulmonary embolism patients Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Evaluation of a novel clinic for management of Chronic Thromboembolic Pulmonary Disease (CTED) and associated Pulmonary Hypertension (CTEPH). Source: International Congress 2017 – PAH and CTEPH Year: 2017 Alteration of factors associated with coagulation in provoked pulmonary embolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Global burden of chronic thromboembolic pulmonary hypertension (CTEPH): An epidemiological analysis Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 The incidence of chronic thromboembolic pulmonary hypertension secondary to acute pulmonary thromboembolism Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Recurrence patterns for venous thromboembolism - who is most at risk? Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Poor Subpleural Perfusion as a predictor of Failure after Balloon Pulmonary Angioplasty for non-operable Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Long-term screening for pulmonary hypertension after pulmonary embolism Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 HbA1c-levels in patients with operable chronic thromboembolic pulmonary hypertension Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Electrocardiographic abnormalities in patients with low or moderate risk pulmonary embolism: Prevalence and association with PO2 /FiO2 ratio Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 The impact of Initial Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism: a French prospective cohort. Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism Year: 2020 Iron Deficiency in Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019